Osisko Development Corp. (“
Osisko Development” or
the “
Company”) is pleased to announce results from
its ongoing underground exploration program on the recently
acquired Tintic project and its 100% owned Trixie Mine
(“
Trixie”), as well as mineral claims covering
more than 17,000 acres (including over 14,200 acres of which are
patented) located in Central Utah’s historic Tintic Mining District
(together with Trixie, the “
Tintic Project”).
Summary
- Trixie is one of several gold and
base metal targets within the larger Tintic Project. The discovery
of the T2 and T4 mineralized structures at Trixie in late 2020 by
Tintic Consolidated Metals, LLC (“TCM”) showed
gold (“Au”) and silver (“Ag”)
grades associated with high sulphidation alteration hosted within
quartzites that are capped by impermeable shales and
volcanics.
- Current underground mining
activities at Trixie are directed by the exploration sampling and
drilling results.
- Results shown below are derived
from 703 samples collected across a total of 183 sites (site ID 783
to 934) near the 625 ft level at Trixie across a total combined
strike length of 650 ft. (~200 m). See Figure 1.
- The sample results indicate
anomalous gold results throughout the entire sampled area, and
along exploration cross-cuts (Figure 1).
- The mineralized structures remain
open along strike and at depth and significant potential exists to
expand the known mineralization.
- The Company is currently expanding
underground developments and utilizing one underground diamond
drill rig and one surface reverse circulation rig to aid in the
delineation of an initial mineral resource estimate by the end of
Q4 2022. Results from this drilling program are pending.
Assay Highlights
- 31.79 oz/t Au and
9.07 oz/t Ag over 4.8 ft. at site 738 (1,089.83 g/t
Au and 310.93 g/t Ag over 1.46 m) including
|
- 76.11 oz/t Au and
21.76 oz/t Ag over 2.0 ft. (2,609.65 g/t Au and
746.22 g/t Ag over 0.61 m)
|
- 6.07 oz/t Au and
11.02 oz/t Ag over 9.0 ft. at site 742 (208.20 g/t
Au and 377.87 g/t Ag over 2.74 m)
|
- 10.28 oz/t Au and
8.60 oz/t Ag over 6.6 ft. at site 746 (352.56 g/t
Au and 294.87 g/t Ag over 2.01 m) including
|
- 26.28 oz/t Au and
21.01 oz/t Ag over 2.5 ft. (901.03 g/t Au and
720.25 g/t Ag over 0.76 m)
|
- 9.03 oz/t Au and
9.72 oz/t Ag over 6.7 ft. at site 747 (309.48 g/t
Au and 333.35 g/t Ag over 2.04 m)
|
- 15.31 oz/t Au and
49.43 oz/t Ag over 4.8 ft. at site 787 (525.02 g/t
Au and 1,694.76 g/t Ag over 1.46 m) including
|
- 33.35 oz/t Au and
104.90 oz/t Ag over 2.0 ft. (1,143.35 g/t Au and
3,596.74 g/t Ag over 0.61 m)
|
- 8.95 oz/t Au and
7.67 oz/t Ag over 16.0 ft. at site 792 (306.97 g/t
Au and 262.91 g/t Ag over 4.88 m) including
|
- 23.28 oz/t Au and
11.03 oz/t Ag over 2.0 ft. (798.05 g/t Au and
378.23 g/t Ag over 0.61 m)
|
- 12.60 oz/t Au and
22.50 oz/t Ag over 4.0 ft. at site 878 (432.04 g/t
Au and 771.44 g/t Ag over 1.22 m)
|
- 4.62 oz/t Au and
6.95 oz/t Ag over 12.0 ft. at site 889 (158.23 g/t
Au and 238.30 g/t Ag over 3.66 m)
|
- 20.26 oz/t Au and
15.76 oz/t Ag over 6.4 ft. at site 893 (694.50 g/t
Au and 540.37 g/t Ag over 1.95 m) including
|
- 108.57 oz/t Au and
71.60 oz/t Ag over 1.1 ft. (3,722.31 g/t Au and
2,454.88 g/t Ag over 0.34 m)
|
- 80.85 oz/t Au and
66.20 oz/t Ag over 4.5 ft. at site 896 (2,771.97 g/t
Au and 2,269.69 g/t Ag over 1.3716 m) including
|
- 157.23 oz/t Au and
128.17 oz/t Ag over 2.3 ft. (5,390.78 g/t Au and
4,394.48 g/t Ag over 0.70 m)
|
- 11.97 oz/t Au and
17.20 oz/t Ag over 5.5 ft. at site 898 (410.31 g/t
Au and 589.75 g/t Ag over 1.68 m) including
|
- 41.72 oz/t Au and
59.72 oz/t Ag over 1.5 ft. (1,430.44 g/t Au and
2,047.51 g/t Ag over 0.46 m)
|
- 17.70 oz/t Au and
7.11 oz/t Ag over 5.0 ft. at site 910 (606.75 g/t
Au and 243.87 g/t Ag over 1.52 m) including
|
- 51.03 oz/t Au and
13.35 oz/t Ag over 1.0 ft. (1,749.76 g/t Au and
457.69 g/t Ag over 0.30 m)
|
- 33.61 oz/t Au and
6.25 oz/t Ag over 4.0 ft. at site 911 (1,152.40 g/t
Au and 214.18 g/t Ag over 1.22 m) including
|
- 121.05 oz/t Au and
12.42 oz/t Ag over 1.0 ft. (4,150.15 g/t Au and
425.99 g/t Ag over 0.30 m)
|
- 79.45 oz/t Au and
6.27 oz/t Ag over 5.5 ft. at site 913 (2,724.03 g/t
Au and 215.12 g/t Ag over 1.68 m) including
|
- 434.09 oz/t Au and
33.65 oz/t Ag over 1.0 ft. (14,883.2 g/t Au and
1,153.72 g/t Ag over 0.30 m)
|
- 16.63 oz/t Au and
2.49 oz/t Ag over 5.0 ft. at site 914 (570.32 g/t
Au and 85.46 g/t Ag over 1.52 m) including
|
- 26.47 oz/t Au and
3.86 oz/t Ag over 2.0 ft. (907.44 g/t Au and
132.26 g/t Ag over 0.61 m)
|
A length weighted composite for each face Site
ID is shown in Table 1 and individual higher grade samples are also
identified within the composite. Samples are collected in feet and
assays are reported in g/t Au. Conversions to metric and imperial
are rounded to two decimal places.
Chris Lodder, President of Osisko Development
commented, “The Trixie underground sampling results from 2020 to
present show exceptional continuity of high grades associated with
the T2 structure. These 2022 samples along with the historic
sampling by TCM, and in combination with the ongoing exploration
developments within the present 720 ft strike by 175 ft vertical by
80 ft wide zone gives Osisko Development with a strong base for
present mining activity and initial resources estimation. We will
continue to use the present shaft / hoist at Trixie but we
anticipate to increase access and mining capacity to the 625 ft and
lower levels of Trixie through a new underground ramp initiated
very recently and expected to reach the 625 ft level in Q1
2023.”
The T2 and T4 mineralized structures are
associated with high-sulphidation epithermal mineralization,
structurally controlled and hosted within the brittle Tintic
Quartzite and capped by the impermeable shales of the Lower Ophir
Formation. The T2 structure is 1 to 8 ft. wide (0.3 m to 2.4m) and
mineralization consists of native Au, and rare Au-Ag – rich
telluride minerals with quartz. The T4 is a mineralized stockwork
zone ranging from to 10 to 80 ft. (3 m to 25 m) and located in the
hanging wall of the T2 and is comprised of Au-Ag rich
mineralization in host rock quartzite with quartz-barite-sulphosalt
stockwork veining. Mineralization currently defined over 220 meters
(720 feet) in strike and reports consistent multi-ounce gold grades
along its entire strike length.
Face Sampling Methodology
As most structures at Trixie are steeply dipping
to the east or west, current sampling procedures are designed to
sample the structure. Channel samples are collected and do not
exceed 3 ft. (1.0 m) in length. The face is washed for safety, and
for better identification of mineralization, alteration and
structures. The hangingwall and footwall of the structures are
marked up on the face and back, samples intervals are marked up and
follow lithological contacts.
For further information on Tintic, including
additional production details please see the technical report on
the Tintic Project, entitled "Technical Report on the Tintic
Project, East Tintic Mining District, Utah County, Utah, USA",
dated June 10, 2022 (effective date of June 7, 2022), and filed at
www.sedar.com under the profile of the Company.
Figure 1: 625 L Map with Select
Assay Highlights is available
athttps://www.globenewswire.com/NewsRoom/AttachmentNg/e1a09397-52ab-411b-ae55-c458f8ee95fb
Qualified Persons
Per National Instrument 43-101 Standards of
Disclosure for Mineral Projects, Maggie Layman, P.Geo. Vice
President Exploration of Osisko Development Corp., is a Qualified
Person and has prepared, validated, and approved the technical and
scientific content of this news release.
Quality Assurance (QA)/Quality Control
(QC)
All underground face samples are collected by
TCM geologists from each of the active mining faces, with samples
transported by the geologists from Trixie to the on-site TCM
laboratory located at the Burgin administrative complex.
Underground samples are dried, crushed to <10 mm and a 250 g
split is taken. The split is pulverized, and a 30 g Fire Assay with
gravimetric finish is completed to determine gold and silver
grades, reported in oz./short ton and g/t.
The TCM Burgin laboratory is not a certified
analytical laboratory, but the facility is managed by a qualified
Laboratory Manager with annual auditing by technical staff.
Inter-laboratory check assays using ALS Laboratory as a third-party
independent analysis of samples is routinely carried out as part of
ongoing QA/QC work. Certified OREAS Quality Control
(“QC”) standards and blanks are inserted at
regular intervals in the sample stream to monitor laboratory
performance.
All drill core and exploration samples are
dispatched to ALS Laboratory for offsite sample preparation and
analysis. Samples are assigned a unique sample ID. All geological
and sampling information is entered into Datashed database. Core is
sawn in half and half are sampled. Certified standards and blanks
inserted into all sample dispatches. Samples are collected by Old
Dominion Transportation and dispatched to ALS Laboratory in Reno,
NV. Sample submission forms accompany the samples, and digital
copies emailed to ALS.
All sample preparation is completed by ALS,
including crushing and pulverizing (Prep31) of samples. Analytical
assay include gold and silver by fire assay of 50g sample with AAS
finish (Au-AA26), over limits by gravimetric analysis (Au-Grav22).
Multi element analysis is by four acid digest (ME-MS61). The pulps
are returned to TCM and coarse rejects are disposed after 90 days.
Assays are reported to TCM, and then loaded into Datashed, QA/QC
samples are checked, and assays merged with sample information for
future reporting.
Cautionary Statements
The Company cautions that the decision to
commence production at Trixie in the form of small scale
underground mining and batch vat leaching has been made without the
benefit of a feasibility study, or reported mineral resources or
mineral reserves, demonstrating economic and technical viability,
and, as a result there may be increased uncertainty of achieving
any particular level of recovery of material or the cost of such
recovery. The Company cautions that historically, such projects
have a much higher risk of economic and technical failure. There is
no guarantee that production will continue as anticipated or at all
or that anticipated production costs will be achieved. The failure
to continue production may have a material adverse impact on the
Company's ability to generate revenue and cash flow to fund
operations. Failure to achieve the anticipated production costs may
have a material adverse impact on the Company's cash flow and
potential profitability. In continuing current operations at Trixie
after closing, the Company will not be basing its decision to
continue such operations on a feasibility study, or reported
mineral resources or mineral reserves demonstrating economic and
technical viability. The Company cautions that mining at Trixie
could be suspended at any time.
The Company is subject to the reporting
requirements of the applicable Canadian securities laws, and as a
result reports information regarding mineral properties,
mineralization and estimates of mineral reserves and mineral
resources, including the information in the Tintic Technical Report
and this news release, in accordance with Canadian reporting
requirements, which are governed by NI 43-101. As such, such
information concerning mineral properties, mineralization and
estimates of mineral reserves and mineral resources, including the
information in the Tintic Technical Report and this news release,
is not comparable to similar information made public by U.S.
companies subject to the reporting and disclosure requirements of
the SEC.
About Osisko Development
Corp.
Osisko Development Corp. is uniquely positioned
as a premier gold development company in North America to advance
the Cariboo Gold Project and other Canadian, U.S.A. and Mexican
properties, with the objective of becoming the next mid-tier gold
producer. The Cariboo Gold Project, located in central British
Columbia, Canada, is Osisko Development's flagship asset. The
considerable exploration potential at depth and along strike
distinguishes the Cariboo Gold Project relative to other
development assets. Osisko Development's project pipeline is
complemented by its interest in the San Antonio gold project,
located in Sonora, Mexico and the Trixie gold test mine, located in
Utah, U.S.A.
For further information about Osisko Development
[(NYSE: ODV; TSX-V:ODV)], please visit www.osiskodevelopment.com or
follow us on Twitter @OsiskoDev
Investor Contact: Jean Francois
Lemonde VP, Investor Relations jflemonde@osiskodev.com Tel:
514-299-4926
Forward-looking Statements
Certain statements contained in this news
release may be deemed "forward-looking statements" within the
meaning of the United States Private Securities Litigation Reform
Act of 1995 and "forward-looking information" within the meaning of
applicable Canadian securities legislation. These forward‐looking
statements, by their nature, require Osisko Development to make
certain assumptions and necessarily involve known and unknown risks
and uncertainties that could cause actual results to differ
materially from those expressed or implied in these forward‐looking
statements. Forward‐looking statements are not guarantees of
performance. Words such as "may", "will", "would", "could",
"expect", "believe", "plan", "anticipate", "intend", "estimate",
"continue", or the negative or comparable terminology, as well as
terms usually used in the future and the conditional, are intended
to identify forward‐looking statements. Information contained in
forward‐looking statements is based upon certain material
assumptions that were applied in drawing a conclusion or making a
forecast or projection, including management's perceptions of
historical trends, current conditions and expected future
developments, results of further exploration work to define and
expand mineral resources, and that the deposit remains open for
expansion at depth and down plunge, as well as other considerations
that are believed to be appropriate in the circumstances, and any
other information herein that is not a historical fact may be
"forward looking information". Material assumptions also include,
management's perceptions of historical trends, current conditions
and expected future developments, results of further exploration
work to define or expand any mineral resources, the ability to
continue production at its Trixie mine, as well as other
considerations that are believed to be appropriate in the
circumstances. Osisko Development considers its assumptions to be
reasonable based on information currently available, but cautions
the reader that their assumptions regarding future events, many of
which are beyond the control of Osisko Development, may ultimately
prove to be incorrect since they are subject to risks and
uncertainties that affect Osisko Development and its business. Such
risks and uncertainties include, among others, risks relating to
capital market conditions, the ability to continue current
production, regulatory framework, the ability of exploration
activities (including drill results) to accurately predict
mineralization; errors in management's geological modelling; the
ability of to complete further exploration activities, including
drilling; property and stream interests in the Project; the ability
of the Company to obtain required approvals; the results of
exploration activities; risks relating to exploration, development
and mining activities; the global economic climate; metal prices;
dilution; environmental risks; and community and non-governmental
actions and the responses of relevant governments to the COVID-19
outbreak and the effectiveness of such responses. Readers are urged
to consult the disclosure provided under the heading "Risk Factors"
in the Company's annual information form for the year ended
December 31, 2021, as amended, which has been filed on SEDAR
(www.sedar.com) under Osisko Development's issuer profile and on
the SEC's EDGAR website (www.sec.gov), for further information
regarding the risks and other factors applicable to the exploration
results. Although the Company's believes the expectations conveyed
by the forward-looking statements are reasonable based on
information available at the date of preparation, no assurances can
be given as to future results, levels of activity and achievements.
The Company disclaims any obligation to update any forward-looking
statements, whether as a result of new information, future events
or results or otherwise, except as required by law. There can be no
assurance that these forward-looking statements will prove to be
accurate, as actual results and future events could differ
materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward-looking
statements.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this news release. No stock exchange,
securities commission or other regulatory authority has approved or
disapproved the information contained herein.
Table 1: 2022 Length Weighted Assay Composites at Trixie
|
Imperial |
Metric |
Site ID |
|
Depth from (ft.) |
Depth to (ft.) |
Length (ft.) |
Au oz/t |
Ag oz/t |
Depth from (m) |
Depth to (m) |
Length (m) |
Au (g/t) |
Ag (g/t) |
738 |
|
0.0 |
4.8 |
4.8 |
31.79 |
9.07 |
0.00 |
1.46 |
1.46 |
1,089.83 |
310.93 |
738 |
including |
1.5 |
3.5 |
2.0 |
76.11 |
21.76 |
0.46 |
1.07 |
0.61 |
2,609.65 |
746.22 |
739 |
|
0.0 |
8.3 |
8.3 |
0.97 |
2.29 |
0.00 |
2.53 |
2.53 |
33.29 |
78.47 |
739 |
including |
3.0 |
5.7 |
2.7 |
1.34 |
4.41 |
0.91 |
1.74 |
0.82 |
45.88 |
151.30 |
739 |
and |
5.7 |
6.9 |
1.2 |
2.51 |
4.60 |
1.74 |
2.10 |
0.37 |
85.92 |
157.86 |
740 |
|
0.0 |
4.0 |
4.0 |
4.73 |
5.66 |
0.00 |
1.22 |
1.22 |
162.22 |
194.22 |
740 |
including |
2.3 |
4.0 |
1.7 |
11.13 |
13.33 |
0.70 |
1.22 |
0.52 |
381.60 |
456.97 |
741 |
|
0.0 |
2.7 |
2.7 |
0.43 |
0.00 |
0.00 |
0.82 |
0.82 |
14.78 |
0.01 |
741 |
including |
1.2 |
2.4 |
1.2 |
0.95 |
0.00 |
0.37 |
0.73 |
0.37 |
32.66 |
0.01 |
742 |
|
0.0 |
9.0 |
9.0 |
6.07 |
11.02 |
0.00 |
2.74 |
2.74 |
208.20 |
377.87 |
742 |
including |
4.0 |
7.3 |
3.3 |
3.09 |
6.42 |
1.22 |
2.23 |
1.01 |
105.98 |
220.16 |
742 |
and |
7.3 |
9.0 |
1.7 |
25.99 |
45.88 |
2.23 |
2.74 |
0.52 |
890.97 |
1,573.11 |
743 |
|
0.0 |
3.7 |
3.7 |
4.58 |
2.04 |
0.00 |
1.13 |
1.13 |
156.97 |
70.03 |
743 |
including |
0.0 |
1.5 |
1.5 |
10.01 |
5.04 |
0.00 |
0.46 |
0.46 |
343.03 |
172.73 |
744 |
|
0.0 |
6.6 |
6.6 |
5.00 |
2.45 |
0.00 |
2.01 |
2.01 |
171.39 |
84.05 |
744 |
including |
1.5 |
3.8 |
2.3 |
13.87 |
5.24 |
0.46 |
1.16 |
0.70 |
475.69 |
179.60 |
745 |
|
0.0 |
7.7 |
7.7 |
1.32 |
2.12 |
0.00 |
2.35 |
2.35 |
45.12 |
72.86 |
745 |
including |
4.2 |
6.7 |
2.5 |
3.48 |
5.50 |
1.28 |
2.04 |
0.76 |
119.33 |
188.62 |
746 |
|
0.0 |
6.6 |
6.6 |
10.28 |
8.60 |
0.00 |
2.01 |
2.01 |
352.56 |
294.87 |
746 |
including |
2.3 |
4.8 |
2.5 |
26.28 |
21.01 |
0.70 |
1.46 |
0.76 |
901.03 |
720.25 |
747 |
|
0.0 |
6.7 |
6.7 |
9.03 |
9.72 |
0.00 |
2.04 |
2.04 |
309.48 |
333.35 |
747 |
including |
0.0 |
1.2 |
1.2 |
30.54 |
21.52 |
0.00 |
0.37 |
0.37 |
1,047.03 |
737.97 |
747 |
and |
1.2 |
2.3 |
1.1 |
16.59 |
29.89 |
0.37 |
0.70 |
0.34 |
568.84 |
1,024.73 |
747 |
and |
2.3 |
3.3 |
1.0 |
1.02 |
2.85 |
0.70 |
1.01 |
0.30 |
35.14 |
97.67 |
747 |
and |
5.5 |
6.7 |
1.2 |
3.23 |
1.87 |
1.68 |
2.04 |
0.37 |
110.78 |
64.02 |
748 |
|
0.0 |
5.4 |
5.4 |
0.65 |
1.19 |
0.00 |
1.65 |
1.65 |
22.12 |
40.93 |
748 |
including |
1.9 |
3.0 |
1.1 |
3.13 |
5.17 |
0.58 |
0.91 |
0.34 |
107.19 |
177.21 |
749 |
|
0.0 |
5.4 |
5.4 |
1.26 |
1.89 |
0.00 |
1.65 |
1.65 |
43.25 |
64.78 |
749 |
including |
2.3 |
4.4 |
2.1 |
2.96 |
4.54 |
0.70 |
1.34 |
0.64 |
101.61 |
155.54 |
750 |
|
0.0 |
5.0 |
5.0 |
1.13 |
2.91 |
0.00 |
1.52 |
1.52 |
38.90 |
99.93 |
750 |
including |
2.4 |
3.4 |
1.0 |
5.50 |
14.57 |
0.73 |
1.04 |
0.30 |
188.41 |
499.62 |
751 |
|
0.0 |
6.0 |
6.0 |
0.13 |
0.26 |
0.00 |
1.83 |
1.83 |
4.29 |
8.91 |
751 |
including |
2.8 |
5.0 |
2.2 |
0.27 |
0.46 |
0.85 |
1.52 |
0.67 |
9.13 |
15.75 |
752 |
|
0.0 |
5.0 |
5.0 |
0.13 |
0.47 |
0.00 |
1.52 |
1.52 |
4.51 |
15.96 |
753 |
|
0.0 |
11.4 |
11.4 |
3.02 |
6.73 |
0.00 |
3.47 |
3.47 |
103.67 |
230.61 |
753 |
including |
2.0 |
3.5 |
1.5 |
0.66 |
2.42 |
0.61 |
1.07 |
0.46 |
22.63 |
82.93 |
753 |
and |
3.5 |
5.4 |
1.9 |
8.10 |
19.11 |
1.07 |
1.65 |
0.58 |
277.65 |
655.33 |
753 |
and |
5.4 |
7.4 |
2.0 |
2.25 |
6.65 |
1.65 |
2.26 |
0.61 |
77.24 |
227.91 |
753 |
and |
7.4 |
9.2 |
1.8 |
0.54 |
1.69 |
2.26 |
2.80 |
0.55 |
18.62 |
58.11 |
753 |
and |
9.2 |
10.4 |
1.2 |
10.33 |
16.63 |
2.80 |
3.17 |
0.37 |
354.13 |
570.24 |
754 |
|
0.0 |
4.2 |
4.2 |
0.08 |
0.22 |
0.00 |
1.28 |
1.28 |
2.73 |
7.68 |
755 |
|
0.0 |
3.0 |
3.0 |
0.20 |
0.92 |
0.00 |
0.91 |
0.91 |
6.85 |
31.50 |
755 |
including |
2.3 |
3.0 |
0.7 |
0.73 |
2.11 |
0.70 |
0.91 |
0.21 |
24.90 |
72.40 |
756 |
|
0.0 |
3.5 |
3.5 |
0.10 |
0.14 |
0.00 |
1.07 |
1.07 |
3.33 |
4.91 |
756 |
including |
1.0 |
2.0 |
1.0 |
0.28 |
0.26 |
0.30 |
0.61 |
0.30 |
9.66 |
8.98 |
757 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
758 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
759 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
760 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
761 |
|
0.0 |
3.7 |
3.7 |
0.06 |
0.32 |
0.00 |
1.13 |
1.13 |
2.02 |
10.99 |
761 |
including |
1.7 |
2.0 |
0.3 |
0.43 |
1.01 |
0.52 |
0.61 |
0.09 |
14.63 |
34.65 |
762 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
763 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
764 |
|
91.0 |
111.0 |
20.0 |
0.06 |
0.23 |
27.74 |
33.83 |
6.10 |
1.91 |
8.04 |
764 |
including |
97.0 |
99.0 |
2.0 |
0.52 |
0.00 |
29.57 |
30.18 |
0.61 |
17.86 |
0.01 |
769 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
770 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
771 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
772 |
|
0.0 |
5.0 |
5.0 |
0.09 |
0.24 |
0.00 |
1.52 |
1.52 |
3.24 |
8.08 |
772 |
including |
2.7 |
3.5 |
0.8 |
0.57 |
1.37 |
0.82 |
1.07 |
0.24 |
19.40 |
46.90 |
773 |
|
0.0 |
10.4 |
10.4 |
0.04 |
1.76 |
0.00 |
3.17 |
3.17 |
1.23 |
60.33 |
773 |
including |
7.9 |
9.4 |
1.5 |
0.24 |
10.01 |
2.41 |
2.87 |
0.46 |
8.26 |
343.34 |
774 |
|
0.0 |
8.5 |
8.5 |
0.01 |
0.59 |
0.00 |
2.59 |
2.59 |
0.51 |
20.07 |
774 |
including |
8.0 |
8.5 |
0.5 |
0.07 |
5.69 |
2.44 |
2.59 |
0.15 |
2.43 |
195.17 |
775 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
776 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
777 |
|
0.0 |
8.0 |
8.0 |
0.07 |
0.23 |
0.00 |
2.44 |
2.44 |
2.50 |
8.00 |
777 |
including |
5.0 |
8.0 |
3.0 |
0.18 |
0.45 |
1.52 |
2.44 |
0.91 |
6.09 |
15.58 |
778 |
|
0.0 |
7.0 |
7.0 |
0.31 |
0.59 |
0.00 |
2.13 |
2.13 |
10.65 |
20.22 |
778 |
including |
0.0 |
3.4 |
3.4 |
0.30 |
0.00 |
0.00 |
1.04 |
1.04 |
10.18 |
0.01 |
778 |
and |
3.4 |
5.0 |
1.6 |
0.72 |
2.58 |
1.04 |
1.52 |
0.49 |
24.64 |
88.42 |
779 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
780 |
|
0.0 |
4.3 |
4.3 |
3.26 |
2.56 |
0.00 |
1.31 |
1.31 |
111.90 |
87.77 |
780 |
|
0.0 |
2.0 |
2.0 |
6.99 |
5.50 |
0.00 |
0.61 |
0.61 |
239.49 |
188.69 |
781 |
|
0.0 |
8.0 |
8.0 |
0.55 |
1.05 |
0.00 |
2.44 |
2.44 |
18.82 |
35.96 |
781 |
including |
3.0 |
4.0 |
1.0 |
4.31 |
7.86 |
0.91 |
1.22 |
0.30 |
147.65 |
269.39 |
782 |
|
0.0 |
3.0 |
3.0 |
1.29 |
1.84 |
0.00 |
0.91 |
0.91 |
44.11 |
63.25 |
783 |
|
0.0 |
7.5 |
7.5 |
0.03 |
0.24 |
0.00 |
2.29 |
2.29 |
1.08 |
8.20 |
783 |
including |
6.1 |
7.0 |
0.9 |
0.15 |
1.17 |
1.86 |
2.13 |
0.27 |
5.14 |
40.26 |
784 |
|
0.0 |
3.6 |
3.6 |
0.27 |
3.27 |
0.00 |
1.10 |
1.10 |
9.22 |
112.27 |
784 |
including |
0.0 |
0.6 |
0.6 |
0.35 |
4.36 |
0.00 |
0.18 |
0.18 |
11.94 |
149.52 |
784 |
and |
0.6 |
1.6 |
1.0 |
0.62 |
6.04 |
0.18 |
0.49 |
0.30 |
21.20 |
207.01 |
785 |
|
0.0 |
8.1 |
8.1 |
0.07 |
0.56 |
0.00 |
2.47 |
2.47 |
2.50 |
19.14 |
785 |
including |
1.2 |
4.8 |
3.6 |
0.15 |
0.97 |
0.37 |
1.46 |
1.10 |
5.25 |
33.32 |
786 |
|
0.0 |
3.2 |
3.2 |
1.36 |
5.25 |
0.00 |
0.98 |
0.98 |
46.74 |
180.17 |
786 |
including |
2.4 |
3.2 |
0.8 |
4.19 |
6.27 |
0.73 |
0.98 |
0.24 |
143.56 |
214.94 |
787 |
|
0.0 |
4.8 |
4.8 |
15.31 |
49.43 |
0.00 |
1.46 |
1.46 |
525.02 |
1,694.76 |
787 |
including |
0.0 |
0.8 |
0.8 |
8.41 |
32.15 |
0.00 |
0.24 |
0.24 |
288.38 |
1,102.30 |
787 |
and |
0.8 |
2.8 |
2.0 |
33.35 |
104.90 |
0.24 |
0.85 |
0.61 |
1,143.35 |
3,596.74 |
788 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
790 |
|
0.0 |
2.5 |
2.5 |
4.09 |
26.72 |
0.00 |
0.76 |
0.76 |
140.11 |
916.14 |
790 |
including |
0.0 |
1.5 |
1.5 |
6.13 |
40.27 |
0.00 |
0.46 |
0.46 |
210.11 |
1,380.78 |
791 |
|
0.0 |
14.0 |
14.0 |
0.61 |
0.44 |
0.00 |
4.27 |
4.27 |
20.89 |
14.99 |
791 |
including |
2.0 |
4.0 |
2.0 |
3.76 |
1.92 |
0.61 |
1.22 |
0.61 |
129.04 |
65.86 |
792 |
|
0.0 |
16.0 |
16.0 |
8.95 |
7.67 |
0.00 |
4.88 |
4.88 |
306.97 |
262.91 |
792 |
including |
4.0 |
6.0 |
2.0 |
18.50 |
23.32 |
1.22 |
1.83 |
0.61 |
634.42 |
799.42 |
792 |
and |
6.0 |
8.0 |
2.0 |
17.32 |
16.21 |
1.83 |
2.44 |
0.61 |
593.69 |
555.85 |
792 |
and |
10.0 |
12.0 |
2.0 |
4.43 |
2.95 |
3.05 |
3.66 |
0.61 |
151.73 |
101.06 |
792 |
and |
12.0 |
14.0 |
2.0 |
3.52 |
0.66 |
3.66 |
4.27 |
0.61 |
120.84 |
22.49 |
792 |
and |
14.0 |
16.0 |
2.0 |
23.28 |
11.03 |
4.27 |
4.88 |
0.61 |
798.05 |
378.23 |
793 |
|
0.0 |
5.0 |
5.0 |
0.44 |
2.96 |
0.00 |
1.52 |
1.52 |
15.25 |
101.41 |
793 |
including |
0.0 |
3.5 |
3.5 |
0.63 |
3.39 |
0.00 |
1.07 |
1.07 |
21.56 |
116.15 |
794 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
795 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
796 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
797 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
798 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
799 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
800 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
801 |
|
0.0 |
6.0 |
6.0 |
0.19 |
0.60 |
0.00 |
1.83 |
1.83 |
6.55 |
20.55 |
801 |
including |
4.0 |
4.6 |
0.6 |
0.52 |
1.33 |
1.22 |
1.40 |
0.18 |
17.84 |
45.43 |
801 |
and |
5.3 |
6.0 |
0.7 |
0.81 |
3.70 |
1.62 |
1.83 |
0.21 |
27.83 |
126.97 |
802 |
|
0.0 |
4.9 |
4.9 |
0.36 |
1.72 |
0.00 |
1.49 |
1.49 |
12.29 |
58.84 |
802 |
including |
2.4 |
4.9 |
2.5 |
0.65 |
3.24 |
0.73 |
1.49 |
0.76 |
22.33 |
111.01 |
803 |
|
0.0 |
5.1 |
5.1 |
0.17 |
3.06 |
0.00 |
1.55 |
1.55 |
5.81 |
104.89 |
805 |
|
0.0 |
6.5 |
6.5 |
1.68 |
0.93 |
0.00 |
1.98 |
1.98 |
57.66 |
32.04 |
805 |
including |
0.0 |
3.5 |
3.5 |
0.34 |
0.38 |
0.00 |
1.07 |
1.07 |
11.58 |
13.12 |
805 |
and |
3.5 |
5.5 |
2.0 |
4.07 |
2.07 |
1.07 |
1.68 |
0.61 |
139.59 |
71.05 |
805 |
and |
5.5 |
6.5 |
1.0 |
1.61 |
0.59 |
1.68 |
1.98 |
0.30 |
55.06 |
20.21 |
806 |
|
0.0 |
6.0 |
6.0 |
0.02 |
0.43 |
0.00 |
1.83 |
1.83 |
0.54 |
14.91 |
806 |
including |
0.0 |
0.5 |
0.5 |
0.09 |
1.20 |
0.00 |
0.15 |
0.15 |
3.15 |
41.02 |
807 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
810 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
811 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
812 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
813 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
814 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
815 |
|
0.0 |
6.5 |
6.5 |
1.36 |
2.31 |
0.00 |
1.98 |
1.98 |
46.77 |
79.13 |
815 |
including |
3.0 |
4.5 |
1.5 |
0.65 |
1.42 |
0.91 |
1.37 |
0.46 |
22.24 |
48.53 |
815 |
and |
4.5 |
6.5 |
2.0 |
3.95 |
6.07 |
1.37 |
1.98 |
0.61 |
135.31 |
208.23 |
816 |
|
0.0 |
5.9 |
5.9 |
0.17 |
1.08 |
0.00 |
1.80 |
1.80 |
5.76 |
37.17 |
816 |
including |
4.9 |
5.9 |
1.0 |
0.47 |
0.86 |
1.49 |
1.80 |
0.30 |
16.25 |
29.45 |
817 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
818 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
819 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
820 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
821 |
|
0.0 |
4.0 |
4.0 |
0.87 |
2.77 |
0.00 |
1.22 |
1.22 |
29.89 |
94.81 |
821 |
including |
0.0 |
2.4 |
2.4 |
1.16 |
2.54 |
0.00 |
0.73 |
0.73 |
39.76 |
86.99 |
821 |
and |
2.4 |
3.4 |
1.0 |
0.68 |
4.79 |
0.73 |
1.04 |
0.30 |
23.28 |
164.31 |
822 |
|
0.0 |
4.7 |
4.7 |
0.23 |
0.51 |
0.00 |
1.43 |
1.43 |
7.92 |
17.37 |
822 |
including |
0.0 |
1.0 |
1.0 |
1.06 |
2.25 |
0.00 |
0.30 |
0.30 |
36.24 |
77.12 |
823 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
824 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
825 |
|
0.0 |
4.4 |
4.4 |
0.08 |
1.03 |
0.00 |
1.34 |
1.34 |
2.69 |
35.23 |
825 |
including |
2.8 |
3.8 |
1.0 |
0.26 |
3.16 |
0.85 |
1.16 |
0.30 |
9.05 |
108.22 |
826 |
|
0.0 |
5.7 |
5.7 |
0.08 |
0.60 |
0.00 |
1.74 |
1.74 |
2.84 |
20.52 |
826 |
including |
1.5 |
3.0 |
1.5 |
0.19 |
1.07 |
0.46 |
0.91 |
0.46 |
6.58 |
36.68 |
827 |
|
0.0 |
4.9 |
4.9 |
0.04 |
0.60 |
0.00 |
1.49 |
1.49 |
1.28 |
20.40 |
828 |
|
0.0 |
8.0 |
8.0 |
0.06 |
0.64 |
0.00 |
2.44 |
2.44 |
2.12 |
22.08 |
828 |
including |
6.0 |
8.0 |
2.0 |
0.25 |
2.24 |
1.83 |
2.44 |
0.61 |
8.43 |
76.83 |
829 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
830 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
831 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
832 |
|
0.0 |
14.0 |
14.0 |
1.30 |
3.33 |
0.00 |
4.27 |
4.27 |
44.67 |
114.18 |
832 |
including |
0.0 |
2.0 |
2.0 |
0.49 |
0.20 |
0.00 |
0.61 |
0.61 |
16.73 |
6.82 |
832 |
and |
6.0 |
8.0 |
2.0 |
1.13 |
11.25 |
1.83 |
2.44 |
0.61 |
38.66 |
385.61 |
832 |
and |
8.0 |
10.0 |
2.0 |
6.54 |
10.32 |
2.44 |
3.05 |
0.61 |
224.19 |
353.74 |
832 |
and |
10.0 |
12.0 |
2.0 |
0.72 |
1.38 |
3.05 |
3.66 |
0.61 |
24.81 |
47.22 |
833 |
|
0.0 |
14.0 |
14.0 |
0.33 |
0.70 |
0.00 |
4.27 |
4.27 |
11.29 |
24.13 |
833 |
including |
4.0 |
6.0 |
2.0 |
0.23 |
0.89 |
1.22 |
1.83 |
0.61 |
8.02 |
30.53 |
833 |
and |
6.0 |
8.0 |
2.0 |
1.50 |
2.86 |
1.83 |
2.44 |
0.61 |
51.47 |
98.08 |
833 |
and |
12.0 |
14.0 |
2.0 |
0.51 |
0.33 |
3.66 |
4.27 |
0.61 |
17.58 |
11.27 |
834 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
835 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
836 |
|
0.0 |
3.9 |
3.9 |
0.03 |
1.78 |
0.00 |
1.19 |
1.19 |
0.95 |
60.88 |
837 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
838 |
|
0.0 |
18.0 |
18.0 |
0.33 |
1.57 |
0.00 |
5.49 |
5.49 |
11.33 |
53.96 |
838 |
including |
0.0 |
3.0 |
3.0 |
0.72 |
3.69 |
0.00 |
0.91 |
0.91 |
24.85 |
126.64 |
838 |
and |
6.0 |
9.0 |
3.0 |
1.07 |
4.18 |
1.83 |
2.74 |
0.91 |
36.54 |
143.16 |
840 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
841 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
842 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
843 |
|
0.0 |
6.2 |
6.2 |
0.04 |
1.10 |
0.00 |
1.89 |
1.89 |
1.54 |
37.82 |
844 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
845 |
|
0.0 |
4.5 |
4.5 |
0.09 |
0.39 |
0.00 |
1.37 |
1.37 |
3.08 |
13.50 |
845 |
including |
2.0 |
4.5 |
2.5 |
0.15 |
0.53 |
0.61 |
1.37 |
0.76 |
5.21 |
18.14 |
846 |
|
0.0 |
7.0 |
7.0 |
0.19 |
0.76 |
0.00 |
2.13 |
2.13 |
6.58 |
26.17 |
846 |
including |
4.0 |
7.0 |
3.0 |
0.42 |
1.29 |
1.22 |
2.13 |
0.91 |
14.33 |
44.09 |
847 |
|
0.0 |
7.0 |
7.0 |
0.95 |
2.58 |
0.00 |
2.13 |
2.13 |
32.45 |
88.39 |
847 |
including |
5.5 |
7.0 |
1.5 |
4.22 |
11.38 |
1.68 |
2.13 |
0.46 |
144.74 |
390.30 |
848 |
|
0.0 |
6.0 |
5.4 |
3.87 |
4.30 |
0.00 |
1.83 |
1.65 |
132.68 |
147.32 |
848 |
including |
0.0 |
2.6 |
2.6 |
3.44 |
6.28 |
0.00 |
0.79 |
0.79 |
118.10 |
215.46 |
848 |
and |
2.6 |
5.0 |
2.4 |
4.97 |
2.86 |
0.79 |
1.52 |
0.73 |
170.41 |
98.05 |
849 |
|
0.0 |
6.4 |
6.4 |
0.73 |
3.13 |
0.00 |
1.95 |
1.95 |
24.96 |
107.31 |
849 |
including |
3.0 |
5.0 |
2.0 |
1.99 |
6.74 |
0.91 |
1.52 |
0.61 |
68.22 |
231.13 |
850 |
|
0.0 |
4.8 |
4.8 |
4.28 |
3.18 |
0.00 |
1.46 |
1.46 |
146.80 |
108.93 |
850 |
including |
1.7 |
2.4 |
0.7 |
28.02 |
16.58 |
0.52 |
0.73 |
0.21 |
960.82 |
568.50 |
851 |
|
0.0 |
3.0 |
3.0 |
0.17 |
0.86 |
0.00 |
0.91 |
0.91 |
5.84 |
29.48 |
851 |
including |
2.0 |
3.0 |
1.0 |
0.39 |
1.36 |
0.61 |
0.91 |
0.30 |
13.40 |
46.79 |
852 |
|
0.0 |
5.7 |
5.7 |
0.17 |
1.65 |
0.00 |
1.74 |
1.74 |
5.78 |
56.70 |
852 |
including |
4.7 |
5.7 |
1.0 |
0.78 |
0.78 |
1.43 |
1.74 |
0.30 |
26.64 |
26.77 |
853 |
|
0.0 |
4.0 |
4.0 |
0.40 |
1.64 |
0.00 |
1.22 |
1.22 |
13.75 |
56.29 |
853 |
including |
0.0 |
1.0 |
1.0 |
0.93 |
4.49 |
0.00 |
0.30 |
0.30 |
31.95 |
153.93 |
853 |
and |
2.0 |
3.0 |
1.0 |
0.36 |
0.65 |
0.61 |
0.91 |
0.30 |
12.34 |
22.39 |
854 |
|
0.0 |
5.7 |
5.7 |
0.82 |
1.94 |
0.00 |
1.74 |
1.74 |
28.12 |
66.67 |
854 |
including |
0.0 |
0.7 |
0.7 |
4.06 |
6.82 |
0.00 |
0.21 |
0.21 |
139.05 |
233.94 |
854 |
and |
2.3 |
5.1 |
2.8 |
0.54 |
1.61 |
0.70 |
1.55 |
0.85 |
18.68 |
55.13 |
855 |
|
0.0 |
4.7 |
4.7 |
0.27 |
3.18 |
0.00 |
1.43 |
1.43 |
9.42 |
108.95 |
855 |
including |
0.0 |
1.2 |
1.2 |
0.54 |
8.77 |
0.00 |
0.37 |
0.37 |
18.35 |
300.72 |
856 |
|
0.0 |
4.7 |
4.7 |
1.50 |
0.96 |
0.00 |
1.43 |
1.43 |
51.26 |
32.85 |
856 |
including |
3.0 |
4.7 |
1.7 |
4.03 |
0.00 |
0.91 |
1.43 |
0.52 |
138.10 |
0.01 |
857 |
|
0.0 |
4.6 |
4.6 |
0.43 |
5.48 |
0.00 |
1.40 |
1.40 |
14.65 |
187.93 |
857 |
including |
0.0 |
1.8 |
1.8 |
0.22 |
4.21 |
0.00 |
0.55 |
0.55 |
7.68 |
144.35 |
857 |
and |
3.3 |
4.6 |
1.3 |
1.08 |
9.83 |
1.01 |
1.40 |
0.40 |
37.18 |
337.05 |
858 |
|
0.0 |
3.3 |
3.3 |
0.07 |
1.23 |
0.00 |
1.01 |
1.01 |
2.42 |
42.33 |
859 |
|
0.0 |
3.2 |
3.2 |
0.03 |
1.06 |
0.00 |
0.98 |
0.98 |
1.17 |
36.35 |
860 |
|
0.0 |
8.0 |
8.0 |
0.62 |
5.76 |
0.00 |
2.44 |
2.44 |
21.13 |
197.56 |
860 |
including |
0.0 |
2.0 |
2.0 |
1.80 |
3.25 |
0.00 |
0.61 |
0.61 |
61.62 |
111.48 |
860 |
and |
2.0 |
4.0 |
2.0 |
0.67 |
19.55 |
0.61 |
1.22 |
0.61 |
22.86 |
670.29 |
861 |
|
0.0 |
8.0 |
8.0 |
0.24 |
0.33 |
0.00 |
2.44 |
2.44 |
8.23 |
11.39 |
861 |
including |
0.0 |
2.0 |
2.0 |
0.93 |
0.98 |
0.00 |
0.61 |
0.61 |
31.97 |
33.45 |
862 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
863 |
|
0.0 |
2.3 |
2.3 |
5.44 |
3.18 |
0.00 |
0.70 |
0.70 |
186.58 |
108.93 |
863 |
including |
0.0 |
0.7 |
0.7 |
17.68 |
9.77 |
0.00 |
0.21 |
0.21 |
606.14 |
334.95 |
864 |
|
0.0 |
6.3 |
6.3 |
0.12 |
2.17 |
0.00 |
1.92 |
1.92 |
4.22 |
74.49 |
864 |
including |
3.5 |
5.8 |
2.3 |
0.30 |
3.01 |
1.07 |
1.77 |
0.70 |
10.18 |
103.26 |
865 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
866 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
867 |
|
0.0 |
6.0 |
6.0 |
0.26 |
0.75 |
0.00 |
1.83 |
1.83 |
8.89 |
25.63 |
867 |
including |
0.0 |
3.0 |
3.0 |
0.37 |
0.83 |
0.00 |
0.91 |
0.91 |
12.68 |
28.58 |
868 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
869 |
|
0.0 |
4.0 |
4.0 |
3.76 |
10.87 |
0.00 |
1.22 |
1.22 |
128.78 |
372.67 |
869 |
including |
1.5 |
4.0 |
2.5 |
6.00 |
16.42 |
0.46 |
1.22 |
0.76 |
205.62 |
563.01 |
870 |
|
0.0 |
5.0 |
5.0 |
1.23 |
4.42 |
0.00 |
1.52 |
1.52 |
42.22 |
151.53 |
870 |
including |
0.0 |
2.0 |
2.0 |
3.06 |
10.98 |
0.00 |
0.61 |
0.61 |
105.03 |
376.40 |
871 |
|
0.0 |
3.5 |
3.5 |
0.39 |
1.25 |
0.00 |
1.07 |
1.07 |
13.21 |
42.81 |
871 |
including |
1.0 |
2.5 |
1.5 |
0.89 |
2.79 |
0.30 |
0.76 |
0.46 |
30.48 |
95.68 |
872 |
|
0.0 |
8.0 |
8.0 |
0.38 |
0.96 |
0.00 |
2.44 |
2.44 |
12.97 |
32.82 |
872 |
including |
4.0 |
6.0 |
2.0 |
0.68 |
1.32 |
1.22 |
1.83 |
0.61 |
23.48 |
45.25 |
873 |
|
0.0 |
6.1 |
6.1 |
1.03 |
4.97 |
0.00 |
1.86 |
1.86 |
35.33 |
170.36 |
873 |
including |
1.4 |
2.1 |
0.7 |
5.80 |
16.69 |
0.43 |
0.64 |
0.21 |
198.80 |
572.20 |
874 |
|
0.0 |
3.7 |
3.7 |
3.74 |
90.25 |
0.00 |
1.13 |
1.13 |
128.11 |
3,094.36 |
874 |
including |
0.0 |
1.9 |
1.9 |
6.51 |
50.45 |
0.00 |
0.56 |
0.56 |
223.23 |
1,729.77 |
875 |
|
0.0 |
6.0 |
6.0 |
0.12 |
0.28 |
0.00 |
1.83 |
1.83 |
4.18 |
9.65 |
876 |
|
0.0 |
6.0 |
6.0 |
0.32 |
0.98 |
0.00 |
1.83 |
1.83 |
10.83 |
33.51 |
876 |
including |
0.0 |
3.0 |
3.0 |
0.57 |
1.15 |
0.00 |
0.91 |
0.91 |
19.39 |
39.50 |
877 |
|
0.0 |
3.0 |
3.0 |
5.13 |
35.08 |
0.00 |
0.91 |
0.91 |
175.74 |
1,202.83 |
877 |
including |
0.0 |
2.0 |
2.0 |
7.23 |
48.68 |
0.00 |
0.61 |
0.61 |
247.93 |
1,669.10 |
878 |
|
0.0 |
4.0 |
4.0 |
12.60 |
22.50 |
0.00 |
1.22 |
1.22 |
432.04 |
771.44 |
878 |
including |
0.0 |
0.6 |
0.6 |
15.61 |
29.49 |
0.00 |
0.18 |
0.18 |
535.28 |
1,011.18 |
878 |
and |
0.6 |
1.6 |
1.0 |
16.55 |
72.09 |
0.18 |
0.49 |
0.30 |
567.26 |
2,471.51 |
878 |
and |
1.6 |
3.0 |
1.4 |
17.25 |
0.00 |
0.49 |
0.91 |
0.43 |
591.50 |
0.01 |
879 |
|
0.0 |
4.4 |
4.4 |
5.33 |
2.63 |
0.00 |
1.34 |
1.34 |
182.61 |
90.14 |
879 |
including |
0.0 |
1.6 |
1.6 |
14.43 |
5.97 |
0.00 |
0.49 |
0.49 |
494.63 |
204.62 |
880 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
881 |
|
0.0 |
4.8 |
4.8 |
0.05 |
0.27 |
0.00 |
1.46 |
1.46 |
1.72 |
9.34 |
881 |
including |
0.0 |
1.0 |
1.0 |
0.19 |
0.90 |
0.00 |
0.30 |
0.30 |
6.51 |
30.75 |
882 |
|
0.0 |
8.0 |
8.0 |
0.24 |
0.63 |
0.00 |
2.44 |
2.44 |
8.39 |
21.76 |
882 |
including |
4.0 |
6.0 |
2.0 |
0.51 |
0.69 |
1.22 |
1.83 |
0.61 |
17.45 |
23.79 |
883 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
884 |
|
0.0 |
6.0 |
6.0 |
0.37 |
2.37 |
0.00 |
1.83 |
1.83 |
12.64 |
81.22 |
884 |
including |
0.0 |
3.0 |
3.0 |
0.49 |
4.32 |
0.00 |
0.91 |
0.91 |
16.80 |
147.99 |
885 |
|
0.0 |
4.0 |
4.0 |
0.26 |
3.62 |
0.00 |
1.22 |
1.22 |
8.77 |
124.11 |
885 |
including |
1.0 |
2.0 |
1.0 |
0.31 |
2.62 |
0.30 |
0.61 |
0.30 |
10.66 |
89.86 |
885 |
and |
3.0 |
4.0 |
1.0 |
0.48 |
8.37 |
0.91 |
1.22 |
0.30 |
16.44 |
286.81 |
886 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
887 |
|
0.0 |
6.7 |
6.7 |
4.25 |
18.95 |
0.00 |
2.04 |
2.04 |
145.78 |
649.80 |
887 |
including |
2.8 |
4.0 |
1.2 |
17.81 |
46.14 |
0.85 |
1.22 |
0.37 |
610.55 |
1,581.85 |
889 |
|
0.0 |
12.0 |
12.0 |
4.62 |
6.95 |
0.00 |
3.66 |
3.66 |
158.23 |
238.30 |
889 |
including |
0.0 |
2.0 |
2.0 |
2.65 |
1.83 |
0.00 |
0.61 |
0.61 |
90.81 |
62.70 |
889 |
and |
4.0 |
6.0 |
2.0 |
13.56 |
15.34 |
1.22 |
1.83 |
0.61 |
464.83 |
525.95 |
889 |
and |
6.0 |
8.0 |
2.0 |
9.56 |
20.49 |
1.83 |
2.44 |
0.61 |
327.84 |
702.40 |
889 |
and |
8.0 |
10.0 |
2.0 |
0.69 |
1.91 |
2.44 |
3.05 |
0.61 |
23.65 |
65.55 |
889 |
and |
10.0 |
12.0 |
2.0 |
0.91 |
1.42 |
3.05 |
3.66 |
0.61 |
31.33 |
48.71 |
890 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
891 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
892 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
893 |
|
0.0 |
6.4 |
6.4 |
20.26 |
15.76 |
0.00 |
1.95 |
1.95 |
694.50 |
540.37 |
893 |
including |
0.0 |
3.5 |
3.5 |
2.60 |
5.47 |
0.00 |
1.07 |
1.07 |
89.06 |
187.48 |
893 |
and |
3.5 |
4.6 |
1.1 |
108.57 |
71.60 |
1.07 |
1.40 |
0.34 |
3,722.31 |
2,454.88 |
894 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
895 |
|
0.0 |
10.0 |
10.0 |
0.05 |
0.24 |
0.00 |
3.05 |
3.05 |
1.67 |
8.40 |
895 |
including |
0.0 |
2.0 |
2.0 |
0.21 |
1.05 |
0.00 |
0.61 |
0.61 |
7.31 |
35.83 |
896 |
|
0.0 |
4.5 |
4.5 |
80.85 |
66.20 |
0.00 |
1.37 |
1.37 |
2,771.97 |
2,269.69 |
896 |
including |
1.0 |
3.3 |
2.3 |
157.23 |
128.17 |
0.30 |
1.01 |
0.70 |
5,390.78 |
4,394.48 |
898 |
|
0.0 |
5.5 |
5.5 |
11.97 |
17.20 |
0.00 |
1.68 |
1.68 |
410.31 |
589.75 |
898 |
including |
3.0 |
4.5 |
1.5 |
41.72 |
59.72 |
0.91 |
1.37 |
0.46 |
1,430.44 |
2,047.51 |
898 |
and |
4.5 |
5.5 |
1.0 |
2.95 |
4.99 |
1.37 |
1.68 |
0.30 |
101.17 |
171.13 |
899 |
|
0.0 |
1.8 |
1.8 |
2.16 |
1.40 |
0.00 |
0.55 |
0.55 |
73.96 |
48.00 |
899 |
including |
1.3 |
1.8 |
0.5 |
7.63 |
4.75 |
0.40 |
0.55 |
0.15 |
261.43 |
163.01 |
900 |
|
0.0 |
1.4 |
1.4 |
0.65 |
6.07 |
0.00 |
0.43 |
0.43 |
22.42 |
208.16 |
901 |
|
0.0 |
2.0 |
2.0 |
1.25 |
4.38 |
0.00 |
0.61 |
0.61 |
42.96 |
150.09 |
902 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
903 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
904 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
905 |
|
0.0 |
12.0 |
12.0 |
0.21 |
0.71 |
0.00 |
3.66 |
3.66 |
7.24 |
24.37 |
905 |
including |
0.0 |
3.0 |
3.0 |
0.72 |
1.63 |
0.00 |
0.91 |
0.91 |
24.56 |
55.81 |
906 |
|
0.0 |
12.0 |
12.0 |
1.33 |
3.10 |
0.00 |
3.66 |
3.66 |
45.58 |
106.23 |
906 |
including |
3.0 |
6.0 |
3.0 |
2.40 |
6.86 |
0.91 |
1.83 |
0.91 |
82.21 |
235.04 |
906 |
and |
9.0 |
12.0 |
3.0 |
2.11 |
3.63 |
2.74 |
3.66 |
0.91 |
72.40 |
124.37 |
907 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
908 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
909 |
|
0.0 |
5.0 |
5.0 |
0.55 |
0.82 |
0.00 |
1.52 |
1.52 |
18.73 |
28.27 |
909 |
including |
0.0 |
1.6 |
1.6 |
0.57 |
0.71 |
0.00 |
0.49 |
0.49 |
19.63 |
24.19 |
909 |
and |
1.6 |
3.0 |
1.4 |
1.30 |
1.73 |
0.49 |
0.91 |
0.43 |
44.44 |
59.19 |
910 |
|
0.0 |
5.0 |
5.0 |
17.70 |
7.11 |
0.00 |
1.52 |
1.52 |
606.75 |
243.87 |
910 |
including |
0.0 |
2.0 |
2.0 |
12.55 |
6.64 |
0.00 |
0.61 |
0.61 |
430.14 |
227.71 |
910 |
and |
2.0 |
3.0 |
1.0 |
51.03 |
13.35 |
0.61 |
0.91 |
0.30 |
1,749.76 |
457.69 |
910 |
and |
3.0 |
5.0 |
2.0 |
6.18 |
4.47 |
0.91 |
1.52 |
0.61 |
211.86 |
153.12 |
911 |
|
0.0 |
4.0 |
4.0 |
33.61 |
6.25 |
0.00 |
1.22 |
1.22 |
1,152.40 |
214.18 |
911 |
including |
1.0 |
2.0 |
1.0 |
121.05 |
12.42 |
0.30 |
0.61 |
0.30 |
4,150.15 |
425.99 |
911 |
and |
2.0 |
4.0 |
2.0 |
6.58 |
5.98 |
0.61 |
1.22 |
0.61 |
225.55 |
205.14 |
912 |
|
0.0 |
8.0 |
8.0 |
0.10 |
0.50 |
0.00 |
2.44 |
2.44 |
3.41 |
17.12 |
912 |
including |
0.0 |
2.0 |
2.0 |
0.37 |
0.75 |
0.00 |
0.61 |
0.61 |
12.75 |
25.74 |
913 |
|
0.0 |
5.5 |
5.5 |
79.45 |
6.27 |
0.00 |
1.68 |
1.68 |
2,724.03 |
215.12 |
913 |
including |
1.8 |
2.8 |
1.0 |
434.09 |
33.65 |
0.55 |
0.85 |
0.30 |
14,883.20 |
1,153.72 |
914 |
|
0.0 |
5.0 |
5.0 |
16.63 |
2.49 |
0.00 |
1.52 |
1.52 |
570.32 |
85.46 |
914 |
including |
0.0 |
2.0 |
2.0 |
26.47 |
3.86 |
0.00 |
0.61 |
0.61 |
907.44 |
132.26 |
914 |
and |
2.0 |
3.0 |
1.0 |
24.70 |
2.38 |
0.61 |
0.91 |
0.30 |
846.79 |
81.52 |
914 |
and |
3.0 |
5.0 |
2.0 |
2.77 |
1.18 |
0.91 |
1.52 |
0.61 |
94.96 |
40.62 |
915 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
916 |
|
0.0 |
20.0 |
20.0 |
0.17 |
32.70 |
0.00 |
6.10 |
6.10 |
5.66 |
1,121.28 |
916 |
including |
4.0 |
6.0 |
2.0 |
0.83 |
1.42 |
1.22 |
1.83 |
0.61 |
28.36 |
48.73 |
916 |
and |
16.0 |
18.0 |
2.0 |
0.20 |
322.38 |
4.88 |
5.49 |
0.61 |
7.01 |
11,053.15 |
917 |
|
0.0 |
4.5 |
4.5 |
3.40 |
5.03 |
0.00 |
1.37 |
1.37 |
116.71 |
172.46 |
917 |
including |
0.0 |
1.3 |
1.3 |
2.89 |
1.56 |
0.00 |
0.40 |
0.40 |
98.93 |
53.44 |
917 |
and |
1.3 |
2.6 |
1.3 |
8.47 |
14.44 |
0.40 |
0.79 |
0.40 |
290.57 |
495.25 |
918 |
|
0.0 |
20.0 |
20.0 |
0.23 |
1.55 |
0.00 |
6.10 |
6.10 |
7.78 |
53.15 |
918 |
including |
2.0 |
4.0 |
2.0 |
1.24 |
2.52 |
0.61 |
1.22 |
0.61 |
42.45 |
86.47 |
919 |
|
0.0 |
12.0 |
12.0 |
0.16 |
4.41 |
0.00 |
3.66 |
3.66 |
5.65 |
151.22 |
919 |
including |
10.0 |
12.0 |
2.0 |
0.47 |
3.04 |
3.05 |
3.66 |
0.61 |
16.23 |
104.22 |
920 |
|
0.0 |
12.0 |
12.0 |
0.06 |
1.22 |
0.00 |
3.66 |
3.66 |
2.16 |
41.67 |
921 |
|
0.0 |
4.0 |
4.0 |
0.57 |
1.87 |
0.00 |
1.22 |
1.22 |
19.49 |
63.96 |
921 |
including |
1.6 |
3.3 |
1.7 |
1.31 |
4.30 |
0.49 |
1.01 |
0.52 |
44.81 |
147.42 |
922 |
|
0.0 |
4.9 |
4.9 |
0.33 |
0.39 |
0.00 |
1.49 |
1.49 |
11.45 |
13.23 |
922 |
including |
0.0 |
2.2 |
2.2 |
0.47 |
0.31 |
0.00 |
0.67 |
0.67 |
16.21 |
10.69 |
922 |
and |
2.2 |
3.2 |
1.0 |
0.57 |
0.98 |
0.67 |
0.98 |
0.30 |
19.57 |
33.45 |
923 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
924 |
|
0.0 |
3.8 |
3.8 |
0.31 |
0.57 |
0.00 |
1.16 |
1.16 |
10.61 |
19.64 |
924 |
including |
1.4 |
2.2 |
0.8 |
1.45 |
2.67 |
0.43 |
0.67 |
0.24 |
49.55 |
91.54 |
925 |
|
0.0 |
16.0 |
16.0 |
0.13 |
2.71 |
0.00 |
4.88 |
4.88 |
4.53 |
93.08 |
925 |
including |
10.0 |
12.0 |
2.0 |
0.72 |
14.77 |
3.05 |
3.66 |
0.61 |
24.72 |
506.27 |
926 |
|
0.0 |
16.0 |
16.0 |
0.21 |
2.17 |
0.00 |
4.88 |
4.88 |
7.04 |
74.45 |
926 |
including |
4.0 |
6.0 |
2.0 |
0.66 |
7.21 |
1.22 |
1.83 |
0.61 |
22.76 |
247.31 |
926 |
and |
10.0 |
12.0 |
2.0 |
0.36 |
0.64 |
3.05 |
3.66 |
0.61 |
12.51 |
21.80 |
927 |
|
0.0 |
5.3 |
5.3 |
2.83 |
1.40 |
0.00 |
1.62 |
1.62 |
97.18 |
48.12 |
927 |
|
0.8 |
1.8 |
1.0 |
14.57 |
7.44 |
0.24 |
0.55 |
0.30 |
499.55 |
254.97 |
928 |
No significant assays |
|
|
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
929 |
|
0.0 |
4.0 |
4.0 |
0.23 |
0.50 |
0.00 |
1.22 |
1.22 |
8.01 |
17.07 |
929 |
including |
0.0 |
3.0 |
3.0 |
0.31 |
0.66 |
0.00 |
0.91 |
0.91 |
10.63 |
22.76 |
930 |
|
0.0 |
90.0 |
90.0 |
0.06 |
0.72 |
0.00 |
27.43 |
27.43 |
2.17 |
24.53 |
930 |
including |
25.0 |
30.0 |
5.0 |
0.29 |
0.00 |
7.62 |
9.14 |
1.52 |
10.11 |
0.01 |
930 |
and |
55.0 |
60.0 |
5.0 |
0.43 |
10.19 |
16.76 |
18.29 |
1.52 |
14.67 |
349.50 |
931 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
932 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
933 |
No significant assays |
|
|
|
|
|
|
|
|
|
|
934 |
|
0.0 |
6.0 |
6.0 |
0.02 |
0.31 |
0.00 |
1.83 |
1.83 |
0.75 |
10.58 |
Osisko Development (TSXV:ODV)
Historical Stock Chart
From Jun 2024 to Jul 2024
Osisko Development (TSXV:ODV)
Historical Stock Chart
From Jul 2023 to Jul 2024